(Total Views: 199)
Posted On: 12/20/2018 1:53:52 PM
Post# of 36567
Now that you mention it - I have been looking for the study protocol and can't find it. Not the part about the payments to the NSABP. I would like to see how many patients, what are the end points, etc.
To be honest, I'm thinking that if results are really good, this trial could end with early approval. More and more cancer drugs are ending early with phase 2 good results. I noticed in the document that outlines the payments to NSABP, there is verbiage about only paying at certain points if the study has not ended. Of course ending early could mean its ending because of problems, but I really doubt it. If it ends early because of great results that would be game changing for Generex and women with TNBC.
To be honest, I'm thinking that if results are really good, this trial could end with early approval. More and more cancer drugs are ending early with phase 2 good results. I noticed in the document that outlines the payments to NSABP, there is verbiage about only paying at certain points if the study has not ended. Of course ending early could mean its ending because of problems, but I really doubt it. If it ends early because of great results that would be game changing for Generex and women with TNBC.
Quote:
Great board!! Any experts on clinical trial progress AE37? It appears GNBT could be linked to Merck NCT02555657.
Read More: https://investorshangout.com/post/view?id=529...z5aFeS9YZo
(1)
(0)
